Literature DB >> 16244283

Differentiation of residual tumor from benign periablational tissues after radiofrequency ablation: the role of MR imaging contrast agents.

Yicheng Ni, Feng Chen, Guy Marchal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16244283     DOI： 10.1148/radiol.2372050400

Source DB:  PubMed          Journal:  Radiology        ISSN： 0033-8419            Impact factor:   11.105


× No keyword cloud information.
  3 in total

1.  Magnetic resonance imaging after radiofrequency ablation in a rodent model of liver tumor: tissue characterization using a novel necrosis-avid contrast agent.

Authors:  Yicheng Ni; Feng Chen; Stefaan Mulier; Xihe Sun; Jie Yu; Willy Landuyt; Guy Marchal; Alfons Verbruggen
Journal:  Eur Radiol       Date:  2006-01-21       Impact factor: 5.315

2.  Current oncologic applications of radiofrequency ablation therapies.

Authors:  Dhruvil R Shah; Sari Green; Angelina Elliot; John P McGahan; Vijay P Khatri
Journal:  World J Gastrointest Oncol       Date:  2013-04-15

Review 3.  Necrosis avidity: a newly discovered feature of hypericin and its preclinical applications in necrosis imaging.

Authors:  Binghu Jiang; Jichen Wang; Yicheng Ni; Feng Chen
Journal:  Theranostics       Date:  2013-08-10       Impact factor: 11.556
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.